Insider · CIK 0001306119

Conroy Kevin T

Reports to the SEC for 9 companies · ABBOTT PARK, IL

sec.gov

Transactions

Companies

Filings

CIK

0001306119

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	ABTABBOTT LABORATORIES · Stock Equivalent UnitsA Award	Director	AAward	+318 sh	$98.83	+$31.4K	551
2026-09-23	ABTABBOTT LABORATORIESF Tax Payment	Director	FTax Payment	−52.5K sh	$103.99	−$5.46M	81,230
2026-06-30	ABTABBOTT LABORATORIES · Stock Equivalent UnitsA Award	Director	AAward	+231 sh	$90.74	+$21K	231
2026-05-20	ALGNALIGN TECHNOLOGY INC · Restricted Stock UnitsA Award	Director	AAward	+1,836 sh	—	—	1,836
2026-05-20	ALGNALIGN TECHNOLOGY INCM Exercise/Conversion	Director	MExercise/Conversion	+1,745 sh	—	—	3,553
2026-05-20	ALGNALIGN TECHNOLOGY INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,745 sh	—	—	0
2026-04-24	ABTABBOTT LABORATORIESA Award	Director	AAward	+2,286 sh	—	—	133,737
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1.4M sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−86.8K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−18.1K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−34.1K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−83.4K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−101K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−46.5K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−29.1K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−235K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−44.3K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPA Award	Director, President and CEO	AAward	+119K sh	—	—	1,397,738
2026-03-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−155K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−117K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−66K sh	—	—	0
2026-02-27	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−13.1K sh	$103.25	−$1.35M	1,278,045
2026-02-27	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.1K sh	—	—	1,260,098
2026-02-27	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+22.2K sh	—	—	1,273,738
2026-02-27	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−18.1K sh	—	—	18,143
2026-02-27	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−8,528 sh	$103.25	−$881K	1,251,570
2026-02-27	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−27.8K sh	—	—	83,360
2026-02-27	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−22.2K sh	—	—	44,336
2026-02-27	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+27.8K sh	—	—	1,291,105
2026-02-27	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−10.4K sh	$103.25	−$1.08M	1,263,319
2026-02-25	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−6,196 sh	$103.45	−$641K	1,241,955
2026-02-25	EXASEXACT SCIENCES CORP · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+155K sh	—	—	154,829
2026-02-25	EXASEXACT SCIENCES CORPA Award	Director, President and CEO	AAward	+13.2K sh	—	—	1,248,151
2025-12-23	EXASEXACT SCIENCES CORPA Award	Director, President and CEO	AAward	+245K sh	—	—	1,101,519
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−115K sh	$101.82	−$11.7M	986,401
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−155K sh	$101.82	−$15.8M	1,234,970
2025-12-23	EXASEXACT SCIENCES CORPA Award	Director, President and CEO	AAward	+331K sh	—	—	155,417
2025-12-23	EXASEXACT SCIENCES CORPA Award	Director, President and CEO	AAward	+138K sh	—	—	1,124,727
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−65K sh	$101.82	−$6.62M	1,059,713
2025-05-21	ALGNALIGN TECHNOLOGY INCM Exercise/Conversion	Director	MExercise/Conversion	+1,148 sh	—	—	1,808
2025-05-21	ALGNALIGN TECHNOLOGY INC · Restricted Stock UnitsA Award	Director	AAward	+1,745 sh	—	—	1,745
2025-05-21	ALGNALIGN TECHNOLOGY INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,148 sh	—	—	0
2025-03-07	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+66.7K sh	$22.38	+$1.49M	1,203,269
2025-03-07	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−48.9K sh	$47.06	−$2.3M	1,154,340
2025-03-07	EXASEXACT SCIENCES CORP · Stock Options (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−66.7K sh	—	—	0
2025-02-28	EXASEXACT SCIENCES CORPF Tax Payment	Director, President and CEO	FTax Payment	−8,528 sh	$47.82	−$408K	1,124,798
2025-02-28	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+22.2K sh	—	—	1,146,965
2025-02-28	EXASEXACT SCIENCES CORPM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.1K sh	—	—	1,133,326
2025-02-28	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−18.1K sh	—	—	36,286
2025-02-28	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−22.2K sh	—	—	66,504

Recent filings

Accepted (ET)
Oct 24
Conroy Kevin T0001104659-26-113286
SEC(opens sec.gov)
Sep 254
Conroy Kevin T0001306119-26-000009
SEC(opens sec.gov)
Jul 14
Conroy Kevin T0001306119-26-000006
SEC(opens sec.gov)
May 224
Conroy Kevin T0001193125-26-237321
SEC(opens sec.gov)
Apr 284
Conroy Kevin T0001306119-26-000004
SEC(opens sec.gov)
Mar 234
Conroy Kevin T0001193125-26-118755
SEC(opens sec.gov)

Companies

Address

100 ABBOTT PARK ROAD

ABBOTT PARK, IL, 60064